Search for: "MERCK, SHARP "
Results 161 - 180
of 262
Sorted by Relevance
|
Sort by Date
25 Mar 2016, 2:11 pm
The Dutch court's reasoning in the parallel case was consistent with the English Court (save they actually granted the relief sought, whereas Kitchin J held that the case for the declaration was arguable) (see Merck Sharpe & Dohme Manufacturing v Ratiopharm Nederland BV and others - February 13 2008 case number/docket number 288241/ HA ZA 07-1689).A new mantra for those clearing the path? [read post]
19 Apr 2011, 5:04 pm
Teva and ratiopharm (EPLAW) Fentanyl – Germany: Federal Court of Justice: Lessons to be learned for claim construction and novelty: Xa ZR 149/07 (Kluwer Patent Blog) Finasteride – France: Tribunale de Grande Instance de Paris: Murder me twice – Merck’s dosage regime patent held invalid again: Teva v Merck Sharp & Dohme (EPLAW) Gaviscon (Sodium alginate, Sodium bicarbonate, Calcium carbonate) – UK: Reckitt Benckiser fined £10.2 M for… [read post]
4 Dec 2011, 1:42 pm
With the consent of the Plaintiffs’ Steering Committee and defendant Merck Sharp & Dohme Corp., the Court hereby appoints John D. [read post]
24 Aug 2008, 10:16 am
.; Dow Corning Ltd; Dyson Technology Ltd; ExxonMobil Chemical Ltd; Ford of Europe; Fujitsu Services Ltd; G E Healthcare; GKN plc; GlaxoSmithKline plc; Hewlett-Packard Ltd; IBM UK Ltd; Infineum UK Ltd; Kodak Ltd; Merck Sharp & Dohme Ltd; Microsoft Ltd; Nestle UK Ltd; Nokia UK Ltd; NXP Semiconductors UK Limited; Pfizer Ltd; Philips Electronics UK Ltd; Pilkington Group Ltd; Procter & Gamble Ltd; QinetiQ Ltd; Renishaw plc; Rohm and Haas (UK) Ltd; Rolls-Royce plc; Shell… [read post]
10 Dec 2007, 1:07 am
"
Vioxx Pact Isn't The End - It's a Beginning "While touted as a virtual end to Vioxx litigation, the $4.85 billion settlement struck by Merck & Co. [read post]
18 Feb 2021, 1:19 am
IntroductionOn 9 May 2019, the South African Constitutional Court, the highest appellate court in South Africa, heard its first ever patent litigation case in Ascendis Animal Health (Pty) Limited v Merck Sharpe Dohme Corporation. [read post]
18 Feb 2021, 1:19 am
IntroductionOn 9 May 2019, the South African Constitutional Court, the highest appellate court in South Africa, heard its first ever patent litigation case in Ascendis Animal Health (Pty) Limited v Merck Sharpe Dohme Corporation. [read post]
13 Jan 2020, 11:56 pm
Late in October last year, the Constitutional Court of South Africa (the ConCourt) handed down its decision on the appropriate default position in patent proceedings in Ascendis Animal Health (Pty) Limited vs Merck Sharp Dohme Corporation and 2 Others [2019] ZACC 41. [read post]
18 Feb 2021, 1:19 am
IntroductionOn 9 May 2019, the South African Constitutional Court, the highest appellate court in South Africa, heard its first ever patent litigation case in Ascendis Animal Health (Pty) Limited v Merck Sharpe Dohme Corporation. [read post]
18 Feb 2021, 1:19 am
IntroductionOn 9 May 2019, the South African Constitutional Court, the highest appellate court in South Africa, heard its first ever patent litigation case in Ascendis Animal Health (Pty) Limited v Merck Sharpe Dohme Corporation. [read post]
23 Feb 2016, 1:53 am
| US trade secrets | Trends in IP Data | EPO's new Chief Economist | GIFs and copyright | Katcall for new positions in the IPKat team | Star Wars IP.Never too late 83 [week ending on Sunday 31 January] – The AmeriKat from the Silicon Valley | INGRES conference on developments in European IP law 2015 - patents | Economics of UK creative industries |Stretchline v H&M | Merck KGaA v Merck Sharp & Dohme | Ethics… [read post]
1 Feb 2013, 11:45 am
Merck, Sharp & Dohme Corp., No. 11-4358, slip op. (2d Cir. [read post]
15 Nov 2020, 6:44 am
The judgement was on the case between Merck Sharp & Dohme Limited (“MSD”) and Wyeth LLC’s (“Wyeth”). [read post]
18 Sep 2020, 7:25 am
That said, one is mindful of the fact that as noted by South Africa’s constitutional court in relation to patent validity challenges in Ascendis Animal Health (Pty) Limited v Merck Sharp Dohme Corporation and 2 Other [2019] ZACC 41 (paragraph 100), in the absence of substantive IP examination systems to balance the monopoly conferred by IPRs, validity challenges should be encouraged as they offer an avenue for IPRs to be tested. [read post]
2 Jan 2015, 4:49 am
But this bit of scimitar-sharp logic did not put a halt to the plaintiff’s case. [read post]
23 Mar 2022, 11:17 pm
Ltd [2022] FCAFC 39 (‘Ono’); and Merck Sharp & Dohme Corp. v Sandoz Pty Ltd [2022] FCAFC 40 (‘MSD’). [read post]
31 Oct 2016, 6:09 am
Johnson & Johnson-Merck Consumer Pharm. [read post]
21 May 2019, 3:51 am
In Merck Sharp & Dohme v. [read post]
13 Dec 2011, 5:49 am
MERCK in Merck Sharp & Dohme Corp. v. [read post]
16 May 2023, 7:33 am
See Merck Sharp & Dohme Corp. v. [read post]
